Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 51 entries
Sorted by: Best Match Show Resources per page
Prostate Tumor Overexpressed-1 (PTOV1) promotes docetaxel-resistance and survival of castration resistant prostate cancer cells.

Oncotarget

Cánovas V, Puñal Y, Maggio V, Redondo E, Marín M, Mellado B, Olivan M, Lleonart M, Planas J, Morote J, Paciucci R.
PMID: 28938627
Oncotarget. 2017 Jul 22;8(35):59165-59180. doi: 10.18632/oncotarget.19467. eCollection 2017 Aug 29.

Metastatic prostate cancer is presently incurable. The oncogenic protein PTOV1, first described in prostate cancer, was reported as overexpressed and significantly correlated with poor survival in numerous tumors. Here, we investigated the role of PTOV1 in prostate cancer survival...

Cite
Cánovas V, Puñal Y, Maggio V, et al. Prostate Tumor Overexpressed-1 (PTOV1) promotes docetaxel-resistance and survival of castration resistant prostate cancer cells. Oncotarget. 2017;8(35):59165-59180doi: 10.18632/oncotarget.19467.
Cánovas, V., Puñal, Y., Maggio, V., Redondo, E., Marín, M., Mellado, B., Olivan, M., Lleonart, M., Planas, J., Morote, J., & Paciucci, R. (2017). Prostate Tumor Overexpressed-1 (PTOV1) promotes docetaxel-resistance and survival of castration resistant prostate cancer cells. Oncotarget, 8(35), 59165-59180. https://doi.org/10.18632/oncotarget.19467
Cánovas, Verónica, et al. "Prostate Tumor Overexpressed-1 (PTOV1) promotes docetaxel-resistance and survival of castration resistant prostate cancer cells." Oncotarget vol. 8,35 (2017): 59165-59180. doi: https://doi.org/10.18632/oncotarget.19467
Cánovas V, Puñal Y, Maggio V, Redondo E, Marín M, Mellado B, Olivan M, Lleonart M, Planas J, Morote J, Paciucci R. Prostate Tumor Overexpressed-1 (PTOV1) promotes docetaxel-resistance and survival of castration resistant prostate cancer cells. Oncotarget. 2017 Jul 22;8(35):59165-59180. doi: 10.18632/oncotarget.19467. eCollection 2017 Aug 29. PMID: 28938627; PMCID: PMC5601723.
Copy Download .nbib Format: NLM
TSPAN1, a novel tetraspanin member highly involved in carcinogenesis and chemoresistance.

Biochimica et biophysica acta. Reviews on cancer

Garcia-Mayea Y, Mir C, Carballo L, Sánchez-García A, Bataller M, LLeonart ME.
PMID: 34979155
Biochim Biophys Acta Rev Cancer. 2021 Dec 31;1877(1):188674. doi: 10.1016/j.bbcan.2021.188674. Epub 2021 Dec 31.

The tetraspanin (TSPAN) family constitutes a poorly explored family of membrane receptors involved in various physiological processes, with relevant roles in anchoring multiple proteins, acting as scaffolding proteins, and cell signaling. Recent studies have increasingly demonstrated the involvement of...

Cite
Garcia-Mayea Y, Mir C, Carballo L, et al. TSPAN1, a novel tetraspanin member highly involved in carcinogenesis and chemoresistance. Biochim Biophys Acta Rev Cancer. 2021;1877(1):188674doi: 10.1016/j.bbcan.2021.188674.
Garcia-Mayea, Y., Mir, C., Carballo, L., Sánchez-García, A., Bataller, M., & LLeonart, M. E. (2021). TSPAN1, a novel tetraspanin member highly involved in carcinogenesis and chemoresistance. Biochimica et biophysica acta. Reviews on cancer, 1877(1), 188674. https://doi.org/10.1016/j.bbcan.2021.188674
Garcia-Mayea, Yoelsis, et al. "TSPAN1, a novel tetraspanin member highly involved in carcinogenesis and chemoresistance." Biochimica et biophysica acta. Reviews on cancer vol. 1877,1 (2021): 188674. doi: https://doi.org/10.1016/j.bbcan.2021.188674
Garcia-Mayea Y, Mir C, Carballo L, Sánchez-García A, Bataller M, LLeonart ME. TSPAN1, a novel tetraspanin member highly involved in carcinogenesis and chemoresistance. Biochim Biophys Acta Rev Cancer. 2021 Dec 31;1877(1):188674. doi: 10.1016/j.bbcan.2021.188674. Epub 2021 Dec 31. PMID: 34979155.
Copy Download .nbib Format: NLM
3D promoter architecture re-organization during iPSC-derived neuronal cell differentiation implicates target genes for neurodevelopmental disorders.

Progress in neurobiology

Su C, Argenziano M, Lu S, Pippin JA, Pahl MC, Leonard ME, Cousminer DL, Johnson ME, Lasconi C, Wells AD, Chesi A, Grant SFA.
PMID: 33545232
Prog Neurobiol. 2021 Jun;201:102000. doi: 10.1016/j.pneurobio.2021.102000. Epub 2021 Feb 02.

Neurodevelopmental disorders are thought to arise from interrupted development of the brain at an early age. Genome-wide association studies (GWAS) have identified hundreds of loci associated with susceptibility to neurodevelopmental disorders; however, which noncoding variants regulate which genes at...

Cite
Su C, Argenziano M, Lu S, et al. 3D promoter architecture re-organization during iPSC-derived neuronal cell differentiation implicates target genes for neurodevelopmental disorders. Prog Neurobiol. 2021;201:102000doi: 10.1016/j.pneurobio.2021.102000.
Su, C., Argenziano, M., Lu, S., Pippin, J. A., Pahl, M. C., Leonard, M. E., Cousminer, D. L., Johnson, M. E., Lasconi, C., Wells, A. D., Chesi, A., & Grant, S. F. A. (2021). 3D promoter architecture re-organization during iPSC-derived neuronal cell differentiation implicates target genes for neurodevelopmental disorders. Progress in neurobiology, 201102000. https://doi.org/10.1016/j.pneurobio.2021.102000
Su, Chun, et al. "3D promoter architecture re-organization during iPSC-derived neuronal cell differentiation implicates target genes for neurodevelopmental disorders." Progress in neurobiology vol. 201 (2021): 102000. doi: https://doi.org/10.1016/j.pneurobio.2021.102000
Su C, Argenziano M, Lu S, Pippin JA, Pahl MC, Leonard ME, Cousminer DL, Johnson ME, Lasconi C, Wells AD, Chesi A, Grant SFA. 3D promoter architecture re-organization during iPSC-derived neuronal cell differentiation implicates target genes for neurodevelopmental disorders. Prog Neurobiol. 2021 Jun;201:102000. doi: 10.1016/j.pneurobio.2021.102000. Epub 2021 Feb 02. PMID: 33545232; PMCID: PMC8096691.
Copy Download .nbib Format: NLM
Genome-wide association study implicates novel loci and reveals candidate effector genes for longitudinal pediatric bone accrual.

Genome biology

Cousminer DL, Wagley Y, Pippin JA, Elhakeem A, Way GP, Pahl MC, McCormack SE, Chesi A, Mitchell JA, Kindler JM, Baird D, Hartley A, Howe L, Kalkwarf HJ, Lappe JM, Lu S, Leonard ME, Johnson ME, Hakonarson H, Gilsanz V, Shepherd JA, Oberfield SE, Greene CS, Kelly A, Lawlor DA, Voight BF, Wells AD, Zemel BS, Hankenson KD, Grant SFA.
PMID: 33397451
Genome Biol. 2021 Jan 04;22(1):1. doi: 10.1186/s13059-020-02207-9.

BACKGROUND: Bone accrual impacts lifelong skeletal health, but genetic discovery has been primarily limited to cross-sectional study designs and hampered by uncertainty about target effector genes. Here, we capture this dynamic phenotype by modeling longitudinal bone accrual across 11,000...

Cite
Cousminer DL, Wagley Y, Pippin JA, et al. Genome-wide association study implicates novel loci and reveals candidate effector genes for longitudinal pediatric bone accrual. Genome Biol. 2021;22(1):1doi: 10.1186/s13059-020-02207-9.
Cousminer, D. L., Wagley, Y., Pippin, J. A., Elhakeem, A., Way, G. P., Pahl, M. C., McCormack, S. E., Chesi, A., Mitchell, J. A., Kindler, J. M., Baird, D., Hartley, A., Howe, L., Kalkwarf, H. J., Lappe, J. M., Lu, S., Leonard, M. E., Johnson, M. E., Hakonarson, H., Gilsanz, V., Shepherd, J. A., Oberfield, S. E., Greene, C. S., Kelly, A., Lawlor, D. A., Voight, B. F., Wells, A. D., Zemel, B. S., Hankenson, K. D., & Grant, S. F. A. (2021). Genome-wide association study implicates novel loci and reveals candidate effector genes for longitudinal pediatric bone accrual. Genome biology, 22(1), 1. https://doi.org/10.1186/s13059-020-02207-9
Cousminer, Diana L, et al. "Genome-wide association study implicates novel loci and reveals candidate effector genes for longitudinal pediatric bone accrual." Genome biology vol. 22,1 (2021): 1. doi: https://doi.org/10.1186/s13059-020-02207-9
Cousminer DL, Wagley Y, Pippin JA, Elhakeem A, Way GP, Pahl MC, McCormack SE, Chesi A, Mitchell JA, Kindler JM, Baird D, Hartley A, Howe L, Kalkwarf HJ, Lappe JM, Lu S, Leonard ME, Johnson ME, Hakonarson H, Gilsanz V, Shepherd JA, Oberfield SE, Greene CS, Kelly A, Lawlor DA, Voight BF, Wells AD, Zemel BS, Hankenson KD, Grant SFA. Genome-wide association study implicates novel loci and reveals candidate effector genes for longitudinal pediatric bone accrual. Genome Biol. 2021 Jan 04;22(1):1. doi: 10.1186/s13059-020-02207-9. PMID: 33397451; PMCID: PMC7780623.
Copy Download .nbib Format: NLM
The Role of Sphingolipids Metabolism in Cancer Drug Resistance.

Frontiers in oncology

Bataller M, Sánchez-García A, Garcia-Mayea Y, Mir C, Rodriguez I, LLeonart ME.
PMID: 35004331
Front Oncol. 2021 Dec 23;11:807636. doi: 10.3389/fonc.2021.807636. eCollection 2021.

Drug resistance continues to be one of the major challenges to cure cancer. As research in this field evolves, it has been proposed that numerous bioactive molecules might be involved in the resistance of cancer cells to certain chemotherapeutics....

Cite
Bataller M, Sánchez-García A, Garcia-Mayea Y, et al. The Role of Sphingolipids Metabolism in Cancer Drug Resistance. Front Oncol. 2021;11:807636doi: 10.3389/fonc.2021.807636.
Bataller, M., Sánchez-García, A., Garcia-Mayea, Y., Mir, C., Rodriguez, I., & LLeonart, M. E. (2021). The Role of Sphingolipids Metabolism in Cancer Drug Resistance. Frontiers in oncology, 11807636. https://doi.org/10.3389/fonc.2021.807636
Bataller, Marina, et al. "The Role of Sphingolipids Metabolism in Cancer Drug Resistance." Frontiers in oncology vol. 11 (2021): 807636. doi: https://doi.org/10.3389/fonc.2021.807636
Bataller M, Sánchez-García A, Garcia-Mayea Y, Mir C, Rodriguez I, LLeonart ME. The Role of Sphingolipids Metabolism in Cancer Drug Resistance. Front Oncol. 2021 Dec 23;11:807636. doi: 10.3389/fonc.2021.807636. eCollection 2021. PMID: 35004331; PMCID: PMC8733468.
Copy Download .nbib Format: NLM
TSPAN1, a novel tetraspanin member highly involved in carcinogenesis and chemoresistance.

Biochimica et biophysica acta. Reviews on cancer

Garcia-Mayea Y, Mir C, Carballo L, Sánchez-García A, Bataller M, LLeonart ME.
PMID: 34979155
Biochim Biophys Acta Rev Cancer. 2021 Dec 31;1877(1):188674. doi: 10.1016/j.bbcan.2021.188674. Epub 2021 Dec 31.

The tetraspanin (TSPAN) family constitutes a poorly explored family of membrane receptors involved in various physiological processes, with relevant roles in anchoring multiple proteins, acting as scaffolding proteins, and cell signaling. Recent studies have increasingly demonstrated the involvement of...

Cite
Garcia-Mayea Y, Mir C, Carballo L, et al. TSPAN1, a novel tetraspanin member highly involved in carcinogenesis and chemoresistance. Biochim Biophys Acta Rev Cancer. 2021;1877(1):188674doi: 10.1016/j.bbcan.2021.188674.
Garcia-Mayea, Y., Mir, C., Carballo, L., Sánchez-García, A., Bataller, M., & LLeonart, M. E. (2021). TSPAN1, a novel tetraspanin member highly involved in carcinogenesis and chemoresistance. Biochimica et biophysica acta. Reviews on cancer, 1877(1), 188674. https://doi.org/10.1016/j.bbcan.2021.188674
Garcia-Mayea, Yoelsis, et al. "TSPAN1, a novel tetraspanin member highly involved in carcinogenesis and chemoresistance." Biochimica et biophysica acta. Reviews on cancer vol. 1877,1 (2021): 188674. doi: https://doi.org/10.1016/j.bbcan.2021.188674
Garcia-Mayea Y, Mir C, Carballo L, Sánchez-García A, Bataller M, LLeonart ME. TSPAN1, a novel tetraspanin member highly involved in carcinogenesis and chemoresistance. Biochim Biophys Acta Rev Cancer. 2021 Dec 31;1877(1):188674. doi: 10.1016/j.bbcan.2021.188674. Epub 2021 Dec 31. PMID: 34979155.
Copy Download .nbib Format: NLM
Corrigendum to "Identification of a putative LPS-associated cation exporter from rhizobium leguminosarum bv. Viciae".

FEMS microbiology letters

Allaway D, Cavalca L, Saini S, Hocking P, Lodwig EM, Leonard ME, Poole PS.
PMID: 10913708
FEMS Microbiol Lett. 2000 Jul 15;188(2):217. doi: 10.1111/j.1574-6968.2000.tb09196.x.

No abstract available.

Cite
Allaway D, Cavalca L, Saini S, et al. Corrigendum to "Identification of a putative LPS-associated cation exporter from rhizobium leguminosarum bv. Viciae". FEMS Microbiol Lett. 2000;188(2):217doi: 10.1111/j.1574-6968.2000.tb09196.x.
Allaway, D., Cavalca, L., Saini, S., Hocking, P., Lodwig, E. M., Leonard, M. E., & Poole, P. S. (2000). Corrigendum to "Identification of a putative LPS-associated cation exporter from rhizobium leguminosarum bv. Viciae". FEMS microbiology letters, 188(2), 217. https://doi.org/10.1111/j.1574-6968.2000.tb09196.x
Allaway, et al. "Corrigendum to "Identification of a putative LPS-associated cation exporter from rhizobium leguminosarum bv. Viciae"." FEMS microbiology letters vol. 188,2 (2000): 217. doi: https://doi.org/10.1111/j.1574-6968.2000.tb09196.x
Allaway D, Cavalca L, Saini S, Hocking P, Lodwig EM, Leonard ME, Poole PS. Corrigendum to "Identification of a putative LPS-associated cation exporter from rhizobium leguminosarum bv. Viciae". FEMS Microbiol Lett. 2000 Jul 15;188(2):217. doi: 10.1111/j.1574-6968.2000.tb09196.x. PMID: 10913708.
Copy Download .nbib Format: NLM
Phosphoglycerate Mutase Cooperates with Chk1 Kinase to Regulate Glycolysis.

iScience

Mikawa T, Shibata E, Shimada M, Ito K, Ito T, Kanda H, Takubo K, Lleonart ME, Inagaki N, Yokode M, Kondoh H.
PMID: 32634742
iScience. 2020 Jul 24;23(7):101306. doi: 10.1016/j.isci.2020.101306. Epub 2020 Jun 24.

Dysregulated glycolysis, including the cancerous Warburg effect, is closely involved in pathological mechanisms of diseased states. Among glycolytic enzymes, phosphoglycerate mutase (PGAM) has been known to exert certain physiological impact in vitro, whereas its regulatory role on glycolysis remains...

Cite
Mikawa T, Shibata E, Shimada M, et al. Phosphoglycerate Mutase Cooperates with Chk1 Kinase to Regulate Glycolysis. iScience. 2020;23(7):101306doi: 10.1016/j.isci.2020.101306.
Mikawa, T., Shibata, E., Shimada, M., Ito, K., Ito, T., Kanda, H., Takubo, K., Lleonart, M. E., Inagaki, N., Yokode, M., & Kondoh, H. (2020). Phosphoglycerate Mutase Cooperates with Chk1 Kinase to Regulate Glycolysis. iScience, 23(7), 101306. https://doi.org/10.1016/j.isci.2020.101306
Mikawa, Takumi, et al. "Phosphoglycerate Mutase Cooperates with Chk1 Kinase to Regulate Glycolysis." iScience vol. 23,7 (2020): 101306. doi: https://doi.org/10.1016/j.isci.2020.101306
Mikawa T, Shibata E, Shimada M, Ito K, Ito T, Kanda H, Takubo K, Lleonart ME, Inagaki N, Yokode M, Kondoh H. Phosphoglycerate Mutase Cooperates with Chk1 Kinase to Regulate Glycolysis. iScience. 2020 Jul 24;23(7):101306. doi: 10.1016/j.isci.2020.101306. Epub 2020 Jun 24. PMID: 32634742; PMCID: PMC7338839.
Copy Download .nbib Format: NLM
Phage-Displayed Peptides Selected to Bind Envelope Glycoprotein Show Antiviral Activity against Dengue Virus Serotype 2.

Advances in virology

de la Guardia C, Quijada M, Lleonart R.
PMID: 29081802
Adv Virol. 2017;2017:1827341. doi: 10.1155/2017/1827341. Epub 2017 Sep 10.

Dengue virus is a growing public health threat that affects hundreds of million peoples every year and leave huge economic and social damage. The virus is transmitted by mosquitoes and the incidence of the disease is increasing, among other...

Cite
de la Guardia C, Quijada M, Lleonart R. Phage-Displayed Peptides Selected to Bind Envelope Glycoprotein Show Antiviral Activity against Dengue Virus Serotype 2. Adv Virol. 2017;2017:1827341doi: 10.1155/2017/1827341.
de la Guardia, C., Quijada, M., & Lleonart, R. (2017). Phage-Displayed Peptides Selected to Bind Envelope Glycoprotein Show Antiviral Activity against Dengue Virus Serotype 2. Advances in virology, 20171827341. https://doi.org/10.1155/2017/1827341
de la Guardia, Carolina, et al. "Phage-Displayed Peptides Selected to Bind Envelope Glycoprotein Show Antiviral Activity against Dengue Virus Serotype 2." Advances in virology vol. 2017 (2017): 1827341. doi: https://doi.org/10.1155/2017/1827341
de la Guardia C, Quijada M, Lleonart R. Phage-Displayed Peptides Selected to Bind Envelope Glycoprotein Show Antiviral Activity against Dengue Virus Serotype 2. Adv Virol. 2017;2017:1827341. doi: 10.1155/2017/1827341. Epub 2017 Sep 10. PMID: 29081802; PMCID: PMC5610824.
Copy Download .nbib Format: NLM
A miniaturized device for the measurement of sheet-metal formability using digital image correlation.

The Review of scientific instruments

Leonard ME, Ugo F, Stout M, Signorelli JW.
PMID: 30184671
Rev Sci Instrum. 2018 Aug;89(8):085114. doi: 10.1063/1.5042053.

A laboratory-scale device to obtain forming-limit diagram data was designed to utilize the Marciniak and Kuczynski (MK) sample geometry. The design uses a high-resolution photographic camera, automatic trigger, and light-emitting diode (LED) lighting to record the time history of...

Cite
Leonard ME, Ugo F, Stout M, et al. A miniaturized device for the measurement of sheet-metal formability using digital image correlation. Rev Sci Instrum. 2018;89(8):085114doi: 10.1063/1.5042053.
Leonard, M. E., Ugo, F., Stout, M., & Signorelli, J. W. (2018). A miniaturized device for the measurement of sheet-metal formability using digital image correlation. The Review of scientific instruments, 89(8), 085114. https://doi.org/10.1063/1.5042053
Leonard, M E, et al. "A miniaturized device for the measurement of sheet-metal formability using digital image correlation." The Review of scientific instruments vol. 89,8 (2018): 085114. doi: https://doi.org/10.1063/1.5042053
Leonard ME, Ugo F, Stout M, Signorelli JW. A miniaturized device for the measurement of sheet-metal formability using digital image correlation. Rev Sci Instrum. 2018 Aug;89(8):085114. doi: 10.1063/1.5042053. PMID: 30184671.
Copy Download .nbib Format: NLM
A world allergy organization international survey on diagnostic procedures and therapies in drug allergy/hypersensitivity.

The World Allergy Organization journal

Thong BY, Mirakian R, Castells M, Pichler W, Romano A, Bonadonna P, Diana D, Kowalski M, Yanez A, Lleonart R, Sanchez-Borges M, Demoly P.
PMID: 23268453
World Allergy Organ J. 2011 Dec;4(12):257-70. doi: 10.1097/WOX.0b013e31823dc02c. Epub 2011 Dec 14.

OBJECTIVE: To study the diagnostic and treatment modalities used in drug allergy/hypersensitivity among members of the World Allergy Organization (WAO).METHODS: A questionnaire comprising 39 questions was circulated electronically to member societies, associate member societies, and regional and affiliate organizations...

Cite
Thong BY, Mirakian R, Castells M, et al. A world allergy organization international survey on diagnostic procedures and therapies in drug allergy/hypersensitivity. World Allergy Organ J. 2011;4(12):257-70doi: 10.1097/WOX.0b013e31823dc02c.
Thong, B. Y., Mirakian, R., Castells, M., Pichler, W., Romano, A., Bonadonna, P., Diana, D., Kowalski, M., Yanez, A., Lleonart, R., Sanchez-Borges, M., & Demoly, P. (2011). A world allergy organization international survey on diagnostic procedures and therapies in drug allergy/hypersensitivity. The World Allergy Organization journal, 4(12), 257-70. https://doi.org/10.1097/WOX.0b013e31823dc02c
Thong, Bernard Yu-Hor, et al. "A world allergy organization international survey on diagnostic procedures and therapies in drug allergy/hypersensitivity." The World Allergy Organization journal vol. 4,12 (2011): 257-70. doi: https://doi.org/10.1097/WOX.0b013e31823dc02c
Thong BY, Mirakian R, Castells M, Pichler W, Romano A, Bonadonna P, Diana D, Kowalski M, Yanez A, Lleonart R, Sanchez-Borges M, Demoly P. A world allergy organization international survey on diagnostic procedures and therapies in drug allergy/hypersensitivity. World Allergy Organ J. 2011 Dec;4(12):257-70. doi: 10.1097/WOX.0b013e31823dc02c. Epub 2011 Dec 14. PMID: 23268453; PMCID: PMC3488913.
Copy Download .nbib Format: NLM
Prospective adherence to specific immunotherapy in Europe (PASTE) survey protocol.

Clinical and translational allergy

Makatsori M, Senna G, Pitsios C, Lleonart R, Klimek L, Nunes C, Rukhadze M, Rogala B, Gawlik R, Panzner P, Pfaar O, Calderon M.
PMID: 25918637
Clin Transl Allergy. 2015 Apr 27;5:17. doi: 10.1186/s13601-015-0060-0. eCollection 2015.

BACKGROUND: Adherence to allergen immunotherapy is important for its effectiveness. There is currently limited data available on allergen immunotherapy adherence outside of clinical trials i.e. in real-life clinical practice. As part of a European Academy of Allergy and Clinical...

Cite
Makatsori M, Senna G, Pitsios C, et al. Prospective adherence to specific immunotherapy in Europe (PASTE) survey protocol. Clin Transl Allergy. 2015;5:17doi: 10.1186/s13601-015-0060-0.
Makatsori, M., Senna, G., Pitsios, C., Lleonart, R., Klimek, L., Nunes, C., Rukhadze, M., Rogala, B., Gawlik, R., Panzner, P., Pfaar, O., & Calderon, M. (2015). Prospective adherence to specific immunotherapy in Europe (PASTE) survey protocol. Clinical and translational allergy, 517. https://doi.org/10.1186/s13601-015-0060-0
Makatsori, Melina, et al. "Prospective adherence to specific immunotherapy in Europe (PASTE) survey protocol." Clinical and translational allergy vol. 5 (2015): 17. doi: https://doi.org/10.1186/s13601-015-0060-0
Makatsori M, Senna G, Pitsios C, Lleonart R, Klimek L, Nunes C, Rukhadze M, Rogala B, Gawlik R, Panzner P, Pfaar O, Calderon M. Prospective adherence to specific immunotherapy in Europe (PASTE) survey protocol. Clin Transl Allergy. 2015 Apr 27;5:17. doi: 10.1186/s13601-015-0060-0. eCollection 2015. PMID: 25918637; PMCID: PMC4410463.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 51 entries